Enovis Flourishes in First Year as Stand-Alone
Enovis reported 4Q22 orthopedic sales of $162.5 million, +10.4% compared to 4Q21. Including contributions from acquisitions, the company generated $599.4...
Feb 27, 2023,
Company Revenue
The Numbers 
Medtronic’s Arsenal of Technology Driving Growth
The company's reported orthopedic sales grew by low-single digits during the third quarter of its 2023 fiscal year....
Feb 27, 2023,
NuVasive’s Cervical and International Sales Drive 2022 Growth
The company exited 2022 with mid-single digit growth despite macro headwinds, driven by its C360 portfolio and international sales....
Feb 24, 2023,
Globus Crossed $1 Billion Threshold in 2022
The company exceeded $1 billion in annual sales for the first time in 2022, representing high-single digit growth compared to...
Feb 23, 2023,
Smith+Nephew Exits 2022 With Improved Execution
The company exited 2022 with early momentum in its plan to revitalize its orthopedics franchise and improve execution....
Feb 22, 2023,
CONMED Suffers Self-Inflicted Wound to End 2022
The company's organic orthopedic sales declined slightly in 2022 as a faulty software implementation hampered 4Q sales....
Feb 07, 2023,
Zimmer Biomet’s Priority Markets Drove 2022 Growth
The company grew in the mid-single digits for 2022 when excluding the impact of foreign currency translation....
Feb 06, 2023,
Stryker Outpaces Market Again in 2022
The company grew in the mid-single digits in 2022, driven by strong performances in joint replacement, trauma and sports medicine....
Feb 02, 2023,
DePuy Synthes Procedure Recovery Offset by China Disruption
The company closed 2022 with a strong sales performance in the U.S. but endured COVID surges in China and...
Jan 26, 2023,
Medtronic Offsets VBP with Strength in U.S.
The company's orthopedic sales grew in the mid-single-digits for FY 2Q23 on the strength of core spine and enabling technology...
Nov 28, 2022,
Loading new posts...
No more posts
